![Leone Patterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leone Patterson
Direktor/Vorstandsmitglied bei
NKARTA, INC.
Vermögen: 116 900 $ am 31.05.2026
Profil
Leone D.
Patterson currently serves as Independent Director at Nkarta, Inc. since 2020, Director at Kalaris Therapeutics, Inc. starting in 2025, and Executive VP, Chief Business & Financial Officer at Zymeworks BC, Inc. beginning in 2024.
Former roles include Independent Non-Executive Director at Oxford Biomedica Plc from 2023 to 2024, Independent Director at Climb Bio, Inc. from 2021 to 2024, Vice President & Corporate Controller at Chiron Corp.
from 1999 to 2006, Vice President-Finance at Exelixis, Inc. from 2007 to 2010, Senior Manager at KPMG LLP from 1989 to 1999, VP-Global Business Planning & Analysis at Novartis AG from 2006 to 2007, Vice President & Global Corporate Controller at NetApp, Inc. from 2010 to 2012, Chief Financial Officer & Vice President at Transcept Pharma, Inc. from 2012 to 2014, Chief Financial Officer at Diadexus, Inc. from 2015 to 2016, President, Chief Financial & Accounting Officer at Adverum Biotechnologies, Inc. in 2021, Executive VP, Chief Financial & Business Officer at Zymeworks, Inc. from 2024 to 2026, and Chief Financial & Business Officer at Tenaya Therapeutics, Inc. from 2021 to 2024.
Education includes undergraduate studies at Chapman University and an MBA from St. Mary's College (Indiana) conferred in 2008.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,01 % | 31.12.2024 | 12.447 ( 0,01 % ) | 105 365 $ | 31.05.2026 |
| 06.01.2026 | 459 ( 0 % ) | 11 535 $ | 31.05.2026 | |
-.--% | 03.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
NKARTA, INC. -.--% | 17.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Leone Patterson
| Unternehmen | Position | Beginn |
|---|---|---|
| NKARTA, INC. | Direktor/Vorstandsmitglied | 27.04.2020 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Finanzdirektor/CFO | 01.09.2024 |
Ehemalige bekannte Positionen von Leone Patterson
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMEWORKS INC. | Finanzdirektor/CFO | 07.01.2026 |
| OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 31.12.2024 |
| CLIMB BIO, INC. | Direktor/Vorstandsmitglied | 01.12.2024 |
| TENAYA THERAPEUTICS, INC. | Finanzdirektor/CFO | 14.08.2024 |
| ADVERUM BIOTECHNOLOGIES, INC. | Vorstandsvorsitzender | 15.06.2020 |
Ausbildung von Leone Patterson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Chapman University
 Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Mary's College (Indiana)
 St. Mary's College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NetApp, Inc.
 NetApp, Inc. Computer PeripheralsElectronic Technology Provides data management and storage solutions | Electronic Technology |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
